Bliss GVS Pharma Limited (BLISSGVS) — Announcement | 12 August 2026

Bliss GVS Pharma announced on August 12, 2026 that its Nomination and Remuneration Committee granted 320,000 stock options under the 2019 Employee Stock Options Plan to eligible employees. The options carry an exercise price of Rs 43 per share, determined with a 91.32% discount to the BSE closing price on August 11, 2026. Vesting occurs in four equal yearly installments starting after 12 months, with a six-month exercise window post-vesting and a six-month lock-in on resulting shares. This grant aligns with SEBI listing requirements and introduces a structured equity incentive mechanism for staff retention.